Brahmi

Names and identification

Language	Name
English	Brahmi
Common Names	Water Hyssop, Brahmi, Bacopa
Hindi	Brahmi
Sanskrit	Brahmi, Saraswati
Latin/Botanical	Bacopa monnieri

Parts Used

• Whole plant
• Leaf

Dosha Effects

Dosha	Effect
Vata	Decreases
Kapha	Decreases
Pitta	Decreases

Key Phytochemical Constituents

• Bacosides A & B
• Bacopasaponins
• Brahmine
• Herpestine
• D-mannitol

Therapeutic Actions (Karma)

• Nootropic
• Anxiolytic
• Memory enhancer
• Neuroprotective
• Antioxidant
• Anti-epileptic

How does it work?

• Active compounds: Bacosides A and B (dammarane-type triterpenoid saponins), betulinic acid, loliolide, asiatic acid, quercetin.
• Neuronal repair: Bacoside aglycone units (jujubogenin/pseudojujubogenin) repair damaged neurons, stimulate kinase activity, restore synaptic function, and improve nerve transmission.
• Acetylcholinesterase inhibition: Quercetin, wogonin, apigenin, and bacopaside X dose-dependently inhibit AChE, with bacopaside X most potent.
• Antioxidant: Increases glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase; decreases malondialdehyde (MDA).
• Anti-inflammatory: Decreases IL-1beta, IL-6, and TNF-alpha; inhibits TNF-alpha and IL-6 release by activated N9 microglial cells.
• NF-kB modulation: Reduces NF-kB phosphorylation to suppress neuroinflammation.
• Alzheimer’s pathology: Modulates GSK-3beta/Wnt/beta-catenin signaling and ameliorates mitochondrial dysfunction.
• Neurotrophic: Induces neurotrophic factors supporting neuronal growth and survival.

How is it used traditionally?

Named after Brahma (creator god) for its intellect-enhancing properties. One of four Medhya Rasayanas in Charaka Samhita. Used for Smriti (memory), Medha (intellect), and Unmada (mental disorders).

Where is it described in the classical texts?

• Charaka Samhita (Medhya Rasayana)
• Sushruta Samhita
• Bhavaprakasha Nighantu

What do recent clinical trials show?

• Lopresti AL, Smith SJ 2025. The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical drug investigation. PMID 41091332 · doi:10.1007/s40261-025-01492-1
  12-week supplementation did not show greater cognitive performance improvement vs placebo, but significantly reduced self-reported stress reactivity and fatigue after cognitive-demanding tasks.
• Dwivedi A, Anjali A, Narzari H and others 2026. Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease: Protocol for an Exploratory Double-Blind, Randomized, Placebo-Controlled Trial. JMIR research protocols. PMID 41740144 · doi:10.2196/82891
  Exploratory trial protocol registered for evaluating efficacy on cognitive function and blood metabolite alterations in MCI and early Alzheimer’s patients.
• Valotto Neto LJ, Reverete de Araujo M, Moretti Junior RC and others 2024. Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis. Antioxidants (Basel, Switzerland). PMID 38671841 · doi:10.3390/antiox13040393
  Comprehensive review confirmed Bacopa’s neuroprotective effects through anti-inflammatory, antioxidant, neurotransmitter modulation, neurotrophic factor induction, and anti-apoptotic mechanisms.
• Sushma, Sahu MR, Murugan NA and others 2024. Amelioration of Amyloid-β Induced Alzheimer’s Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK-3β/Wnt/β-Catenin Signaling. Molecular nutrition & food research. PMID 38143280 · doi:10.1002/mnfr.202300245
  Bacopa monnieri demonstrated significant amelioration of amyloid-beta-induced Alzheimer’s pathology via mitochondrial function restoration and GSK-3beta/Wnt/beta-catenin pathway modulation.

1 further claim previously listed here could not be traced to a published paper and has been removed. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

• Generally well tolerated with high therapeutic index; adverse event rates similar to placebo in clinical trials.
• Most common side effects are gastrointestinal: increased stool frequency, nausea, abdominal cramps.
• Occasional reports of dry mouth, flu-like symptoms, headache, drowsiness (uncommon).
• No serious or severe adverse effects reported in clinical trials.
• Not linked to liver enzyme elevations or clinically apparent liver injury (LiverTox database).
• Drug interactions: May increase side effects of drugs metabolized by the liver (CYP enzymes).
• Caution with cholinergic drugs (donepezil, rivastigmine, galantamine, tacrine) due to additive acetylcholine effects.
• May increase thyroid hormone levels; avoid with thyroid hormone medications and in hyperthyroidism.
• Contraindicated in pregnancy, stomach ulcers, intestinal/urinary blockages, slow heart rate, and lung disease.

Recommended Dosage

Powder: 2-5g/day; Standardized extract (20% bacosides): 300-450mg/day

Safety, contraindications and cautions

• May increase thyroid hormone levels
• GI effects at high doses
• Caution with CNS depressants

What is it made of?

Part(s) Analyzed: Whole herb

Triterpenoid Saponins (Bacosides)

• Bacoside A (8-12%)
• Bacoside B
• Bacopaside I-XII
• Bacopasaponin C
• Jujubogenin glycosides

Alkaloids

• Brahmine
• Herpestine
• Nicotine (trace)

Flavonoids

• Luteolin
• Apigenin
• Luteolin-7-glucoside

Sterols

• Beta-sitosterol
• Stigmasterol
• Stigmastanol

Analytical Methods: HPLC-ELSD (bacosides), LC-MS/MS, UV spectrophotometry

Dosage forms and preparation

Dosage Forms: Churna (powder), Tablet, Capsule, Swarasa (fresh juice), Ghrita (ghee preparation), Taila (oil), Syrup, Brahmi Rasayana

Standard Dosage: 3-6g powder twice daily; 300-450mg standardized extract (50% bacosides); 10-20ml juice; 5-10g Brahmi Ghrita; 5-10ml syrup

Bioavailability: Bacoside A shows moderate oral bioavailability (30-40%) with Tmax of 2-3 hours. Bacosides undergo hydrolysis to jujubogenin and pseudojujubogenin aglycones in the GI tract. Lipid-based formulations (Ghrita) significantly enhance bacoside bioavailability (2-3x). Phosphatidylserine complex of bacosides shows improved brain penetration. SNEDDS formulations achieve 3-4x enhancement. Chronic dosing (8-12 weeks) needed for cognitive effects.

Optimal Timing: Morning with milk or ghee for cognitive enhancement; consistent daily use for 8-12 weeks for full nootropic effect; Ghrita at bedtime for Vata pacification

Standardized Extract: Standardized extract with bacosides NLT 50% (by UV); NLT 25% bacoside A by HPLC. Whole plant extract 10:1 ratio for general preparations.

Shelf Life: 2 years (powder); 3 years (standardized extract capsule/tablet); 3 years (Ghrita); 1 year (syrup)

Storage: Cool, dry place away from light and moisture. Standardized extracts in well-sealed containers. Ghrita in glass jars at room temperature. Hygroscopic powder requires airtight packaging with desiccant.

Marker Compounds: Bacoside A (bacoside A3, bacopaside II, bacopasaponin C, jujubogenin isomer), Bacoside B, Bacosaponin C-F, Luteolin, Apigenin, Brahmine, Herpestine, Betulinic acid

Extraction Methods

• Hydroalcoholic extraction (70:30 ethanol:water) for bacoside enrichment
• Aqueous extraction for traditional preparations
• Methanol extraction for research-grade saponin profiling
• Standardized extraction to 50% bacosides via solvent partitioning
• Traditional Ghrita preparation for lipid-based extraction

Synergistic Combinations

• With Shankhapushpi for Medhya (cognitive enhancement) synergy
• With Ashwagandha for stress-related cognitive decline
• With Jyotishmati (Celastrus) for memory and learning
• With Mandukparni (Gotu kola) for neural regeneration
• With Vacha for speech and cognitive disorders